Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas (original) (raw)
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas
- Y Murakami1,*,
- K Saigo2,
- H Takashima3,
- M Minami3,
- T Okanoue3,
- C Bréchot4,
- P Paterlini-Bréchot4
- 1Department of Gastroenterology, Fukui National Hospital, Fukui, Japan, and Department of Gastroenterology, Kyoto Prefectural University of Medicine, Kyoto, Japan
- 2Second Department of Surgery, Chiba University, Chiba, Japan
- 3Department of Gastroenterology, Kyoto Prefectural University of Medicine, Kyoto, Japan
- 4Institut Pasteur/INSERM U-370, Paris, France
- Correspondence to:
Dr Y Murakami
Department of Gastroenterology, Fukui National Hospital, 33-1 Sakuragaoka, Tsuruga, Fukui 914-0195, Japan; ymurakamivirus.kyoto-u.ac.jp
Abstract
Background and aims: Hepatitis B virus (HBV) DNA integration into or close to cellular genes is frequently detected in HBV positive hepatocellular carcinomas (HCC). We have previously shown that viral integration can lead to aberrant target gene transcription. In this study, we attempted to investigate common pathways to hepatocarcinogenesis.
Methods: By using a modified Alu-polymerase chain reaction approach, we analysed 50 HCCs along with 10 previously published cases.
Results: Sixty eight cellular flanking sequences (seven repetitive or unidentified sequences, 42 cellular genes, and 19 sequences potentially coding for unknown proteins) were obtained. Fifteen cancer related genes and 25 cellular genes were identified. HBV integration recurrently targeted the human telomerase reverse transcriptase gene (three cases) and genes belonging to distinct pathways: calcium signalling related genes, 60s ribosomal protein encoding genes, and platelet derived growth factor and mixed lineage leukaemia encoding genes. Two tumour suppressor genes and five genes involved in the control of apoptosis were also found at the integration site. The viral insertion site was distributed over all chromosomes except 13, X, and Y.
Conclusions: In 61/68 (89.7%) cases, HBV DNA was integrated into cellular genes potentially providing cell growth advantage. Identification of recurrent viral integration sites into genes of the same family allows recognition of common cell signalling pathways activated in hepatocarcinogenesis.
- HCC, hepatocellular carcinoma
- HBV, hepatitis B virus
- hTERT, human telomerase reverse transcriptase
- WHV, Woodchuck hepatitis virus
- HPV, human papillomavirus
- PCR, polymerase chain reaction
- PDGF, platelet derived growth factor
- MLL, mixed lineage leukaemia
- APCL, adenomatous poliposis coli-like
- MGMT, O6-methylguanine DNA methyltransferase
- hepatocellular carcinoma
- hepatitis B virus
- DNA integration
- human telomerase reverse transcriptase
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
- HCC, hepatocellular carcinoma
- HBV, hepatitis B virus
- hTERT, human telomerase reverse transcriptase
- WHV, Woodchuck hepatitis virus
- HPV, human papillomavirus
- PCR, polymerase chain reaction
- PDGF, platelet derived growth factor
- MLL, mixed lineage leukaemia
- APCL, adenomatous poliposis coli-like
- MGMT, O6-methylguanine DNA methyltransferase
- hepatocellular carcinoma
- hepatitis B virus
- DNA integration
- human telomerase reverse transcriptase